Global Autoimmune Diseases Drugs Market Professional Survey Report 2016

June 2016 | 111 pages | ID: G0DFF92822BEN
QYResearch

Abstracts

This report mainly covers the following

Product types including

• Oral
• Parenteral
• Topical

The segment applications including

• Hospital use
• Clinic use
• Household
• Others

Segment regions including (the separated region report can also be offered)

• North America
• Europe
• Japan
• China
• Southeast Asia
• India

The players list (Partly, Players you are interested in can also be added)

• AbbVie Inc.
• Amgen Inc.
• Biogen
• F. Hoffmann-La Roche
• Johnson & Johnson Private Limited
• Pfizer Inc.?
• GSK
• Baxter
• Boehringer Ingelheim
• Eli Lilly
• Merck
• Novartis
• Sandoz
• Sanofi
• Takeda Pharmaceuticals
• Daiichi Sankyo
• UCB
• Acorda Therapeutics
• Eisai
• Vertex Pharmaceuticals

With 20 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF AUTOIMMUNE DISEASES DRUGS

1.1 Definition and Specifications of Autoimmune Diseases Drugs
  1.1.1 Definition of Autoimmune Diseases Drugs
  1.1.2 Specifications of Autoimmune Diseases Drugs
1.2 Classification of Autoimmune Diseases Drugs
  1.2.1 Oral
  1.2.2 Parenteral
  1.2.3 Topical
1.3 Applications of Autoimmune Diseases Drugs
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Household
  1.3.4 Others
1.4 Industry Chain Structure of Autoimmune Diseases Drugs
1.5 Industry Overview and Major Regions Status of Autoimmune Diseases Drugs
  1.5.1 Industry Overview of Autoimmune Diseases Drugs
  1.5.2 Global Major Regions Status of Autoimmune Diseases Drugs
1.6 Industry Policy Analysis of Autoimmune Diseases Drugs
1.7 Industry News Analysis of Autoimmune Diseases Drugs

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AUTOIMMUNE DISEASES DRUGS

2.1 Raw Material Suppliers and Price Analysis of Autoimmune Diseases Drugs
2.2 Equipment Suppliers and Price Analysis of Autoimmune Diseases Drugs
2.3 Labor Cost Analysis of Autoimmune Diseases Drugs
2.4 Other Costs Analysis of Autoimmune Diseases Drugs
2.5 Manufacturing Cost Structure Analysis of Autoimmune Diseases Drugs
2.6 Manufacturing Process Analysis of Autoimmune Diseases Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AUTOIMMUNE DISEASES DRUGS

3.1 Capacity and Commercial Production Date of Global Autoimmune Diseases Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Autoimmune Diseases Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Autoimmune Diseases Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Autoimmune Diseases Drugs Major Manufacturers in 2015

4 GLOBAL AUTOIMMUNE DISEASES DRUGS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Autoimmune Diseases Drugs Capacity and Growth Rate Analysis
  4.2.2 2015 Autoimmune Diseases Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Autoimmune Diseases Drugs Sales and Growth Rate Analysis
  4.3.2 2015 Autoimmune Diseases Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Autoimmune Diseases Drugs Sales Price
  4.4.2 2015 Autoimmune Diseases Drugs Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Autoimmune Diseases Drugs Gross Margin
  4.5.2 2015 Autoimmune Diseases Drugs Gross Margin Analysis (Company Segment)

5 AUTOIMMUNE DISEASES DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Autoimmune Diseases Drugs Market Analysis
  5.1.1 North America Autoimmune Diseases Drugs Market Overview
  5.1.2 North America 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.1.4 North America 2015 Autoimmune Diseases Drugs Market Share Analysis
5.2 Europe Autoimmune Diseases Drugs Market Analysis
  5.2.1 Europe Autoimmune Diseases Drugs Market Overview
  5.2.2 Europe 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.2.4 Europe 2015 Autoimmune Diseases Drugs Market Share Analysis
5.3 Japan Autoimmune Diseases Drugs Market Analysis
  5.3.1 Japan Autoimmune Diseases Drugs Market Overview
  5.3.2 Japan 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Japan 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.3.4 Japan 2015 Autoimmune Diseases Drugs Market Share Analysis
5.4 China Autoimmune Diseases Drugs Market Analysis
  5.4.1 China Autoimmune Diseases Drugs Market Overview
  5.4.2 China 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 China 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.4.4 China 2015 Autoimmune Diseases Drugs Market Share Analysis
5.5 Southeast Asia Autoimmune Diseases Drugs Market Analysis
  5.5.1 Southeast Asia Autoimmune Diseases Drugs Market Overview
  5.5.2 Southeast Asia 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.5.4 Southeast Asia 2015 Autoimmune Diseases Drugs Market Share Analysis
5.6 India Autoimmune Diseases Drugs Market Analysis
  5.6.1 India Autoimmune Diseases Drugs Market Overview
  5.6.2 India 2011-2016E Autoimmune Diseases Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Autoimmune Diseases Drugs Sales Price Analysis
  5.6.4 India 2015 Autoimmune Diseases Drugs Market Share Analysis

6 GLOBAL 2011-2016E AUTOIMMUNE DISEASES DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Autoimmune Diseases Drugs Sales by Type
6.2 Different Types Autoimmune Diseases Drugs Product Interview Price Analysis
6.3 Different Types Autoimmune Diseases Drugs Product Driving Factors Analysis
  6.3.1 Oral Autoimmune Diseases Drugs Growth Driving Factor Analysis
  6.3.2 Parenteral Autoimmune Diseases Drugs Growth Driving Factor Analysis
  6.3.3 Topical Autoimmune Diseases Drugs Growth Driving Factor Analysis

7 GLOBAL 2011-2016E AUTOIMMUNE DISEASES DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Hospital use Autoimmune Diseases Drugs Growth Driving Factor Analysis
  7.3.2 Clinic use Autoimmune Diseases Drugs Growth Driving Factor Analysis
  7.3.3 Household Autoimmune Diseases Drugs Growth Driving Factor Analysis
  7.3.4 Others Autoimmune Diseases Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AUTOIMMUNE DISEASES DRUGS

8.1 AbbVie Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 AbbVie Inc. 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AbbVie Inc. 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.2 Amgen Inc.
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Amgen Inc. 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Amgen Inc. 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.3 Biogen
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Biogen 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Biogen 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.4 F. Hoffmann-La Roche
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 F. Hoffmann-La Roche 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 F. Hoffmann-La Roche 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.5 Johnson & Johnson Private Limited
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Johnson & Johnson Private Limited 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Johnson & Johnson Private Limited 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.6 Pfizer Inc.?
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Pfizer Inc.? 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Pfizer Inc.? 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.7 GSK
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 GSK 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 GSK 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.8 Baxter
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Baxter 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Baxter 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.9 Boehringer Ingelheim
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Boehringer Ingelheim 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Boehringer Ingelheim 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.10 Eli Lilly
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 Eli Lilly 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Eli Lilly 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.11 Merck
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 Merck 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Merck 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.12 Novartis
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Novartis 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Novartis 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.13 Sandoz
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 Sandoz 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Sandoz 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.14 Sanofi
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Sanofi 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Sanofi 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.15 Takeda Pharmaceuticals
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Takeda Pharmaceuticals 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Takeda Pharmaceuticals 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.16 Daiichi Sankyo
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 Daiichi Sankyo 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 Daiichi Sankyo 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.17 UCB
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
  8.17.3 UCB 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.17.4 UCB 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.18 Acorda Therapeutics
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
  8.18.3 Acorda Therapeutics 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.18.4 Acorda Therapeutics 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.19 Eisai
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
  8.19.3 Eisai 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.19.4 Eisai 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis
8.20 Vertex Pharmaceuticals
  8.20.1 Company Profile
  8.20.2 Product Picture and Specifications
  8.20.3 Vertex Pharmaceuticals 2015 Autoimmune Diseases Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.20.4 Vertex Pharmaceuticals 2015 Autoimmune Diseases Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 North America 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
  9.2.2 Europe 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
  9.2.3 Japan 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
  9.2.4 China 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
  9.2.5 Southeast Asia 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
  9.2.6 India 2016-2021 Autoimmune Diseases Drugs Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 AUTOIMMUNE DISEASES DRUGS MARKETING MODEL ANALYSIS

10.1 Autoimmune Diseases Drugs Regional Marketing Model Analysis
10.2 Autoimmune Diseases Drugs International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Autoimmune Diseases Drugs by Regions
10.4 Autoimmune Diseases Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AUTOIMMUNE DISEASES DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF AUTOIMMUNE DISEASES DRUGS

12.1 New Project SWOT Analysis of Autoimmune Diseases Drugs
12.2 New Project Investment Feasibility Analysis of Autoimmune Diseases Drugs

13 CONCLUSION OF THE GLOBAL AUTOIMMUNE DISEASES DRUGS MARKET PROFESSIONAL SURVEY REPORT 2016